Our Networks
National International
Marketing
Domestic Marketing International Marketing Distribution & Logistics Contact Us
R & D
Objectives Products Developed Achievements R&D Infrastructure Future Plans
Our Divisions
Cardia Swift Division Generic Division Gyno Swift Division Institution Division Mega Swift Division Oncrit Division Proposed Divisions Q-den Division
Why Choose Us
Our Presence Strengths Rankings Awards Production Major Break Throughs Products In Pipeline
Investors
Board OF Directors Share Holding Patterns Quarterly Results Annual Reports Corporate Governance Code of Conduct Live Stock In NSE Live Stock in BSE Mergers
Career
Work Culture Career & Growth Employee Benefits HR Contact Details Current Openings Application Form
Media Center
Corporate Film Corporate Brochure Presentation Annual Reports e-Newsletter Image Gallery Ind-Swift in News Interview With MD
CSR

Ind-Swift in collaboration with Wockhardt UK launches Atorvastatin tablets in UK

IND-SWIFT is a Chandigarh based pharmaceutical company, established in 1986 with a mission of winning global customers through innovative pharmaceutical products. Three visionaries Jains, Mehtas and Munjals, dedicated themselves to work for humanity’s quest for longer, happier and healthier lives . IND-SWIFT has been ranked 35th among top Indian Pharmaceutical companies. IND-SWIFT is ISO 9001-2008, WHO GMP certified and is listed on Bombay Stock Exchange and National Stock Exchange . We ensure value for money by developing innovative therapies and processes to produce safe effective and consistent quality pharmaceutical products delivering across the globe. IND-SWIFT is a research driven forward looking pharmaceutical company having world class expertise in finished goods dosage and Active Pharmaceutical Ingredients (API’s) and herbal products. IND-SWIFT is proud to be the second largest drug manufacturers of North India. IND-SWIFT’S multipurpose, multilocation facility layouts are spread across the lush-green plains of northern India. The facilities are built according to current guidelines of MHRA, EU, WHO, and accreditations with ISO 14000 series standards.With strong network presence in more than 45 countries we are committed to provide quality medicines and better health care.

Live Stock Quote for Ind-Swift Limited:

Click Here !!! to Get Free issue of Trendz in Medical world Magazine

Our Products: